Dr. Gerald Maguire, the newly elected Chairman of the National Stuttering Association (NSA), joins Peter Reitzes to discuss the future of the NSA and the role and importance of stuttering self help. On the second half of today’s episode, Dr. Maguire is asked a range of questions about the medical treatment of stuttering.
Dr. Maguire said that in his role as Chairman of the NSA, it is important to “Remember our legacy and at the same time grow for the future. Our mission is simple and bold as we move ahead. Which is essentially meeting the needs of the stuttering community today while searching for the enhanced treatments of tomorrow.”
Dr. Maguire shared that his vision for the future of the NSA includes enhanced fundraising to support the NSA, providing legal counsel to people who stutter related to discrimination, creating a government relations arm and committee, increasing media outreach and funding for stuttering research with a goal of distributing competitive grants in the millions of dollars of range. Dr. Maguire stated that he wants the NSA to “not only be the leading resource for self help, but for education, advocacy and research.”
When asked about finding a balance between “stuttering is okay” and seeking a cure, Dr. Maguire responded, “I like to say that acceptance and searching for treatments do not need to be mutually exclusive. In my other treatments of brain disorders such as major depressive disorder or bipolar disorder, the individual with the disorder accepts the condition but they also accept the nature of the treatment for the condition – things that they have to do to lead a more functional life and a better outcome…”
Dr. Gerlald Maguire is the new Chairman of the Board of the National Stuttering Association, Chair of Psychiatry in the University of California’s Riverside School of Medicine and a professor of psychiatry, is the Kirkup Center Chair in Stuttering Treatment and considered by many to be the leading authority on the medical treatment of stuttering.
Today on StutterTalk we ask Dr. Gerald Maguire what causes stuttering? This is the fourth episode in a series on the cause of stuttering. Dr. Maguire discusses the cause of stuttering while also providing listeners with a research update and much more.
Dr. Maguire is Chair of Psychiatry in the University of California’s, Riverside School of Medicine and a professor of psychiatry. Dr. Maguire is the Kirkup Center Chair in Stuttering Treatment and considered by many to be the leading authority on the medical treatment of stuttering. Jerry is well-published in numerous psychiatric journals. His previous appearances on StutterTalk are archived here.
Dr. Maguire may be contacted via email: gerald.maguire@ucr.edu
Gerald Maguire, M.D., DFAPA joins Peter Reitzes for this “Ask Jerry” episode in which Dr. Maguire answers listener questions about the medical treatment of stuttering.
Dr. Maguire is the newly appointed Chair of Psychiatry in the University of California’s, Riverside School of Medicine and a professor of psychiatry. Dr. Maguire is considered by many to be the leading authority on the medical treatment of stuttering and is a regular guest on StutterTalk. Dr. Maguire has been listed for the past six years in Best Doctors in America and is well-published in numerous psychiatric journals. Jerry’s previous appearances on StutterTalk are archived here.
Dr. Maguire may be contacted via email: gerald.maguire@ucr.edu
Gerald A. Maguire, MD joins Peter Reitzes to discuss what speech-language pathologists need to know about the emerging medical treatments in stuttering.
StutterTalk is excited to announce that this StutterTalk episode or course will be available for 0.10 CEUs for approximately six months, free of charge, through the National Stuttering Association. For complete details regarding the continuing education units being offered by the National Stuttering Association, go to the National Stuttering Association’s CEU page.
Take the CEU Test Here.(expired May 15, 2014)
Show/Course Notes:
Title: What Speech-Language Pathologists Need to Know About the Emerging Medical Treatments in Stuttering
Objectives: At the conclusion of the program, the learner shall be able to:
Identify the new DSM 5 criteria for childhood onset fluency disorder (stuttering)
Summarize available pharmacologic treatments for stuttering and related conditions.
Cite how traditional speech therapy with people who stutter is commonly effected by the medical treatment of stuttering.
Presenter Bio — Gerald A. Maguire, MD, is Sr. Associate Dean of Medical Education, holds the Kirkup Endowed Chair in Stuttering Treatment and is Professor of Clinical Psychiatry at the University of California Irvine School of Medicine. Dr. Maguire is a regular guest on StutterTalk. His previous appearances are archived here. Contact Dr. Maguire directly via email: gerald.maguire@uci.edu.
Episode/Course Description: Stuttering has recently been reclassified in DSM 5 as Childhood Onset Fluency Disorder. Over the past decade, much has been learned regarding the neurophysiologic and genetic basis of stuttering. With such, methods for medical treatments have emerged. Such treatments can potentially be utilized when standard speech therapy techniques have not yielded full benefits or as an augmentation to such treatments.
StutterTalk® is a 501 (c)(3) non-profit organization dedicated to talking openly about stuttering. StutterTalk is the first and longest running podcast on stuttering. Since 2007 we have published more than 700 podcasts which are heard in 180 countries.
2 May 2016
The Future of the National Stuttering Association with Dr. Gerald Maguire (Ep. 578)
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Google Podcasts | Stitcher | TuneIn | RSS
Dr. Gerald Maguire, the newly elected Chairman of the National Stuttering Association (NSA), joins Peter Reitzes to discuss the future of the NSA and the role and importance of stuttering self help. On the second half of today’s episode, Dr. Maguire is asked a range of questions about the medical treatment of stuttering.
Dr. Maguire said that in his role as Chairman of the NSA, it is important to “Remember our legacy and at the same time grow for the future. Our mission is simple and bold as we move ahead. Which is essentially meeting the needs of the stuttering community today while searching for the enhanced treatments of tomorrow.”
Dr. Maguire shared that his vision for the future of the NSA includes enhanced fundraising to support the NSA, providing legal counsel to people who stutter related to discrimination, creating a government relations arm and committee, increasing media outreach and funding for stuttering research with a goal of distributing competitive grants in the millions of dollars of range. Dr. Maguire stated that he wants the NSA to “not only be the leading resource for self help, but for education, advocacy and research.”
When asked about finding a balance between “stuttering is okay” and seeking a cure, Dr. Maguire responded, “I like to say that acceptance and searching for treatments do not need to be mutually exclusive. In my other treatments of brain disorders such as major depressive disorder or bipolar disorder, the individual with the disorder accepts the condition but they also accept the nature of the treatment for the condition – things that they have to do to lead a more functional life and a better outcome…”
Dr. Gerlald Maguire is the new Chairman of the Board of the National Stuttering Association, Chair of Psychiatry in the University of California’s Riverside School of Medicine and a professor of psychiatry, is the Kirkup Center Chair in Stuttering Treatment and considered by many to be the leading authority on the medical treatment of stuttering.
Links: